Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The impact of adjusted work conditions and disease-modifying drugs on work ability in multiple sclerosis.
[Monoclonal antibodies, overview and outlook of a promising therapeutic option].
Influenza vaccination in patients with multiple sclerosis is possible with some considerations.
High-dose erythropoietin in patients with progressive multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Sphingosine-1-phosphate modulators in inflammatory skin diseases-Lining up for clinical translation.
Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach.
Association between Helicobacter pylori infection and multiple sclerosis: A systematic review and meta-analysis.
The Differential Diagnosis of Multiple Sclerosis Using Convex Combination of Infinite Kernels.
Diffusion tensor microscopy data (15.6 μm in-plane) of white matter tracts in the human, pig, and rat spinal cord with corresponding tissue histology.
Altered Intrinsic Pyramidal Neuron Properties and Pathway-Specific Synaptic Dysfunction Underlie Aberrant Hippocampal Network Function in a Mouse Model of Tauopathy.
Mutism Caused by Severe Demyelination in a Patient With Marchiafava-Bignami Disease.
B Cell Malignancies Frequently Target the Autoreactive B Cell Repertoire.
Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS.
Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.
The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.
Differential effects of social isolation in adolescent and adult mice on behavior and cortical gene expression.
[Expression of chemokine like factor-like myelin and lymphocyte and related proteins for vesicle trafficking and membrane link transmembrane domain-containing protein 2 in rats with varicocele].
Does early (treatment in) BENEFIT lead to late MS benefit?
Vitamin D and Systemic Lupus Erythematosus: Myth or Reality?
Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists.
The Gas6/TAM System and Multiple Sclerosis.
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery.
Ultrastructural, ssrDNA sequencing of Myxobolus prochilodus and Myxobolus porofilus and details of the interaction with the host Prochilodus lineatus.
Patients' satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis.

Pages